Candel Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +111.6% | +154.9% | +235.3% | +23.4% | +3.1% | -14.6% | |
| – | +426.8% | +40.6% | -22.1% | +34.0% | +71.9% | -28.1% | |
| – | +169.0% | +114.4% | -195.2% | – | – | – | |
| – | +245.8% | -149.4% | – | -839.4% | – | +533.8% | |
| – | +828.3% | +24.3% | -29.3% | -64.8% | -96.5% | +3,568.8% | |
| – | – | -104.8% | -29.3% | -78.4% | -94.3% | +3,400.0% | |
| – | – | – | – | – | – | – | |
| – | – | +4,228.3% | +0.0% | -100.0% | – | – | |
| – | -97.8% | +14,553.1% | -72.2% | -100.6% | – | -40.5% | |
| – | – | +59.8% | -126.7% | – | – | -74.4% | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.